Abstract View

Author(s): Soham Mandal*1, Moumita karmakar2

Email(s): 1soham.mandal@tnu.in

Address:

    Department of pharmaceutics, School of Pharmacy, The Neotia University, West Bengal.

Published In:   Volume - 2,      Issue - 3,     Year - 2023

DOI: Not Available

 View HTML        View PDF

Please allow Pop-Up for this website to view PDF file.

ABSTRACT:
In industrialised nations, cardiovascular disease (CVD) is the vital cause of death and morbidity. Atherosclerotic lesions that narrow the arterial lumen are the cause of CVD. Development of plaque, reduces blood flow to the heart and usually causes serious consequences. Medication delivery methods alter the drug release profile, absorption, and distribution to treat various disorders while enhancing the effectiveness and safety of the final product. In the rapidly developing field of nanomedicine, materials on the nanoscale are employed as therapeutic agents. The nano-drug delivery system has distinguished itself as an excellent platform for delivering therapeutic agents to a sick location in a more regulated and targeted manner among all the other fascinating uses of nanomaterials. Through site-specificity, reduced toxicity, and target-oriented administration, nanotechnology aims to treat terrifying illnesses while providing various advantages. This review discusses new computer simulations of magnetically targeted nano-pharmacodynamics, nanoparticles, and nano-drug delivery devices.

Cite this article:
Soham Mandal*, Moumita karmakar. Computational Nano- Pharmacodynamics in Cardiovascular Diseases. IJRPAS, March-April 2023; 2(2): 35-43


References not available.

Related Images:



Recent Images



Assessing Philippine Health Care Coverage Gaps: An Assessment of Accessibility of Public Health Programs in Selected Barangay in Imus, Cavite, Philippines
Isoabsorptive UV Spectrophotometry Method development and validation for simultaneous estimation of Eslicarbazepine Acetate and Carbamazepine
To develop and validate the stability indicating method for repaglinide and voglibose using HPLC method
To develop and validate the stability indicating method for Empagliflozin and Linagliptin using HPLC method
A Prospective Observational Study on the Clinical Evaluation of Vertigoin Young Adult Population of Amaravati Capital Region
Quality by Design-Based Analytical Method Development and Validation of Suzetrigine by RP - HPLC
Formulation, Optimization and Evaluation of Rimegepant Pulsatile Tablets for Chronotherapeutic Management of Migraine
Development and Evaluation of Ticagrelor Solid Dispersion Tablets Using PVP K30, PEG 6000 and HPMC E5 for Dissolution Enhancement
To study the effect of various superdisintegrants and binders in the Formulation and Evaluation of Labetalol Rapid Disintegrating Tablet
To Develop and Validate the Stability Indicating Method for Ezetimibe and Rosuvastatin Using HPLC Method

Tags